Compare SGHT & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | ELME |
|---|---|---|
| Founded | 2011 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 198.2M |
| IPO Year | 2021 | 1994 |
| Metric | SGHT | ELME |
|---|---|---|
| Price | $4.00 | $2.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $9.08 | ★ $12.67 |
| AVG Volume (30 Days) | 373.6K | ★ 1.2M |
| Earning Date | 03-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 752.97% |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $77,363,000.00 | ★ $206,360,000.00 |
| Revenue This Year | $11.81 | $5.03 |
| Revenue Next Year | $10.62 | $4.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $1.98 |
| 52 Week High | $9.24 | $17.68 |
| Indicator | SGHT | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 18.07 |
| Support Level | $3.99 | N/A |
| Resistance Level | $4.33 | $2.26 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 69.19 | 36.11 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.